In chaotic meeting, RFK Jr.’s ACIP begins altering childhood vaccine schedule

Initial changes were modest, but panel is now evaluating all vaccines for kids and pregnant people.

September 20, 2025 Check out STAT+

Sponsored By

Elijah Nouvelage/Getty Images In a chaotic meeting, RFK Jr.'s handpicked advisers begin altering the childhood vaccine schedule Kennedy says he wants to restore trust in vaccines. His handpicked ACIP panel raised many doubts, and outside experts were left baffled and frustrated. By Chelsea Cirruzzo, Elaine Chen, and Lizzy Lawrence Crystal Milner/STAT Amid a crackdown on DEI, a group of Black neuroscientists celebrates its growth Black in Neuro attendees say the Trump administration's defunding of efforts to diversify the scientific workforce has created new challenges By Anil Oza Kevin Dietsch/Getty Images 3 key takeaways from the Senate hearing on CDC director's firing and RFK Jr.'s vaccine agenda Changes coming to childhood vaccine schedule, new details on the CDC director's firing, and rising political influence as Kennedy implements his agenda By Daniel Payne and Isabella Cueto STAT+ | Inside the hospital 'war rooms' bracing for Medicaid cuts Hospitals nationwide prepare for nearly $1T in Medicaid cuts, weighing service reductions, consolidation, and new tech as patient care hangs in the balance. By Daniel Payne STAT+ | HHS abruptly cancels CDC meeting with RFK Jr., anti-vaccine activist as scrutiny mounts HHS cancels meeting between Robert F. Kennedy Jr., anti-vaccine activist David Geier, and CDC officials over access to vaccine safety data By O. Rose Broderick STAT+ | The marijuana rescheduling debate is missing the point, experts say Marijuana could soon become a Schedule III drug. Advocates see it as historic, but analysts warn the change may bring more symbolism than real reform. By Lev Facher Opinion: The Trump admin's cruel disbanding of the Pediatric Brain Tumor Consortium Because of the disbanding of the PBTC, children with rare brain cancers may be denied new and promising treatments. By Josie Glausiusz STAT+ | FDA warning letters show how it intends to ratchet up pressure over drug ads The FDA's crackdown is unprecedented, but some experts questioned whether the agency has the staff to carry it out By Lizzy Lawrence and Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser